March 23 (Reuters) – Evelo Biosciences Inc:
* CO AND ABDUL LATIF JAMEEL HEALTH ENTERED INTO A STRATEGIC COLLABORATION
* EVELO BIOSCIENCES-STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE CO’S LEAD INFLAMMATION PRODUCT CANDIDATE EDP1815 IN MIDDLE EAST, TURKEY, AFRICA Source text for Eikon: Further company coverage:
(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.